A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Diagnostic for Personalized Treatment of the BRAF-Mutation-Like Subtype of Colorectal Cancers

High-throughput
Sjors G J G In 't VeldSun Tian

Abstract

Colorectal cancer patients with the BRAF(p.V600E) mutation have poor prognosis in metastatic setting. Personalized treatment options and companion diagnostics are needed to better treat these patients. Previously, we developed a 58-gene signature to characterize the distinct gene expression pattern of BRAF-mutation-like subtype (accuracy 91.1%). Further experiments repurposed drug Vinorelbine as specifically lethal to this BRAF-mutation-like subtype. The aim of this study is to translate this 58-gene signature from a research setting to a robust companion diagnostic that can use formalin-fixed, paraffin-embedded (FFPE) samples to select patients with the BRAF-mutation-like subtype. BRAF mutation and gene expression data of 302 FFPE samples were measured (mutants = 57, wild-type = 245). The performance of the 58-gene signature in FFPE samples showed a high sensitivity of 89.5%. In the identified BRAF-mutation-like subtype group, 50% of tumours were known BRAF mutants, and 50% were BRAF wild-type. The stability of the 58-gene signature in FFPE samples was evaluated by two control samples over 40 independent experiments. The standard deviations (SD) were within the predefined criteria (control 1: SD = 0.091, SD/Range = 3.0%; contr...Continue Reading

References

Jul 3, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Jul 17, 2010·International Journal of Cancer. Journal International Du Cancer·Jeanne TieJayesh Desai
Jan 14, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BokemeyerP Koralewski
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vlad PopoviciMauro Delorenzi
Jan 1, 2014·The Journal of Molecular Diagnostics : JMD·Anna SapinoCharles E Cox
Feb 13, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Filippo PietrantonioSandro Barni
Oct 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott KopetzLeonard Saltz
Apr 9, 2016·Cell·Loredana VecchioneRené Bernards
Nov 1, 2013·Personalized Medicine·Leonie Jm DelahayeAnnuska M Glas

❮ Previous
Next ❯

Citations

Apr 10, 2020·International Journal of Cancer. Journal International Du Cancer·Andreas SchlickerLoredana Vecchione
Jun 25, 2019·ESMO Open·Antonio Mulero-SánchezLoredana Vecchione

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

MoTriColor
Matlab
Agendia

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.